BTB06584
CAS No. 219793-45-0
BTB06584 ( BTB )
Catalog No. M13505 CAS No. 219793-45-0
BTB06584 is a novel acetohydroxyacid synthase(AHAS) inhibitor, a promising drug target against Mycobacterium tuberculosis (MTB).
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 27 | In Stock |
|
5MG | 43 | In Stock |
|
10MG | 60 | In Stock |
|
25MG | 79 | In Stock |
|
50MG | 113 | In Stock |
|
100MG | 203 | In Stock |
|
200MG | 313 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBTB06584
-
NoteResearch use only, not for human use.
-
Brief DescriptionBTB06584 is a novel acetohydroxyacid synthase(AHAS) inhibitor, a promising drug target against Mycobacterium tuberculosis (MTB).
-
DescriptionBTB06584 is a novel acetohydroxyacid synthase(AHAS) inhibitor, a promising drug target against Mycobacterium tuberculosis (MTB). BTB06584 is an IF1-dependent, selective inhibitor of the mitochondrial F1 Fo-ATPase.
-
SynonymsBTB
-
PathwayEndocrinology/Hormones
-
TargetATPase
-
RecptorATPase; Acetohydroxyacid synthase
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number219793-45-0
-
Formula Weight417.82
-
Molecular FormulaC19H12ClNO6S
-
Purity>98%(HPLC)
-
SolubilityDMSO: 84 mg/mL (201.04 mM)
-
SMILESO=S(C1=CC(OC(C2=CC=C(Cl)C=C2)=O)=C([N+]([O-])=O)C=C1)(C3=CC=CC=C3)=O
-
Chemical Name2-nitro-5-(phenylsulfonyl)phenyl 4-chlorobenzoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang D, et al. J Chem Inf Model. 2013 Feb 25;53(2):343-53.
molnova catalog
related products
-
NDI-091143
NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.
-
SB 204990
SB 204990 is an effective and specific ATP citrate lyase enzyme inhibitor.
-
(-)-Denudatin B
(-)-Denudatin B is derived from Magnolia fargesii. (-)-Denudatin B has nonspecific antiplatelet action at high concentration by inhibiting phosphoinositides breakdown induced by collagen and thrombin.